MEDICUS PHARMA LTD (MDCX) Stock Analyst Ratings
NASDAQ:MDCX - Nasdaq - CA58471K2020 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to MDCX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.06. This target is 705.62% above the current price.
MDCX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MDCX.
In the previous month the buy percentage consensus was at a similar level.
MDCX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-08 | Maxim Group | Maintains | Buy -> Buy |
| 2025-04-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-14 | D. Boral Capital | Initiate | Buy |
| 2024-12-17 | Maxim Group | Initiate | Buy |